MetLife Investment Management’s Innovid Corp. CTV Stock Holding History

MetLife Investment Management’s Portfolio CTV Stock Details CTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-67,977	Closed	-$210K	–	2842
2024 Q4	$210K	Buy	67,977 +37,307	+122%	+$88.1K	﹤0.01%	2283
2024 Q3	$55.2K	Buy	30,670 +1,991	+7%	+$3.62K	﹤0.01%	2745
2024 Q2	$53.1K	Buy	+28,679	New	+$61.5K	﹤0.01%	2751
2023 Q1	–	Sell	-31,892	Closed	-$54.5K	–	2820
2022 Q4	$54.5K	Sell	31,892 -17,641	-36%	-$47.8K	﹤0.01%	2747
2022 Q3	$134K	Buy	+49,533	New	+$141K	﹤0.01%	2531

MetLife Investment Management's CTV Position: Q1 2025 in Review

MetLife Investment Management sold out of Innovid Corp. (CTV) in Q1 2025, closing a stake of 67,977 shares — an estimated $210K sold.

MetLife Investment Management first reported a position in CTV in Q3 2022 and held it in 5 quarters. The position peaked at $210K in Q4 2024. 0 funds tracked by Wall St. Rank hold CTV as of Q1 2025.

MetLife Investment Management reported no remaining Innovid Corp. position as of Q1 2025 after selling out during the quarter.
MetLife Investment Management sold 67,977 Innovid Corp. shares in Q1 2025, an estimated $210K.
MetLife Investment Management first reported a position in Innovid Corp. in Q3 2022 and held it in 5 quarters.
MetLife Investment Management's Innovid Corp. position peaked at $210K in Q4 2024.
0 funds tracked by Wall St. Rank held Innovid Corp. as of Q1 2025.

Based on MetLife Investment Management's 13F filing for Q1 2025, filed 14 May 2025.